Kimber Poffenberger, PhD
Chief Strategy Officer
Kimber Poffenberger PhD, joins Codagenix with more than 30 years of experience in biologics research, product development, and regulatory affairs. She has worked in small and mid-sized biotech and big pharma in roles across the spectrum of the product lifecycle: in discovery, quality assurance, project leadership and team management, commercial development and strategy, and regulatory affairs. Her approach to product strategy is informed by many years of experience in vaccines regulatory affairs, supporting end-to-end product development across every stage from preclinical through lifecycle management. Dr. Poffenberger received her BS from Carnegie Mellon university and her PhD in Microbiology from the University of Chicago.